187 related articles for article (PubMed ID: 8390741)
1. Malignant fibrous histiocytoma following bone marrow transplantation for acute leukemia.
Pesce A; Filippi C; Rosenthal E; Taillan B; Garnier G; Vinti H; Gratecos N; Poitou G; Garbe L; Michiels JF
Transplant Proc; 1993 Jun; 25(3):2299-301. PubMed ID: 8390741
[No Abstract] [Full Text] [Related]
2. Allogeneic versus autologous bone marrow transplantation versus chemotherapy for treatment of acute myeloid leukemia in first complete remission (BGM 84 and BGMT 87 studies). The BGMT Group.
Reiffers J; Stoppa AM; Rigal-Huguet F; Michallet M; Marit G; Gastaut JA; Attal M; Corront B; Broustet A; Hollard D
Bone Marrow Transplant; 1991; 7 Suppl 2():36. PubMed ID: 1878709
[No Abstract] [Full Text] [Related]
3. High-dose cytarabine in consolidation chemotherapy or with bone marrow transplantation for patients with acute leukemia: preliminary results.
Champlin R; Jacobs A; Gale RP; Ho W; Selch M; Lenarsky C; Feig SA
Semin Oncol; 1985 Jun; 12(2 Suppl 3):190-5. PubMed ID: 3892702
[No Abstract] [Full Text] [Related]
4. Malignant fibrous histiocytoma secondary to allogeneic bone marrow transplantation.
Iori AP; Arcese W; Pinto RM; Favre C; Macchia P
Bone Marrow Transplant; 1994 Sep; 14(3):492. PubMed ID: 7994282
[No Abstract] [Full Text] [Related]
5. Double intensive consolidation chemotherapy (ICC) for acute myeloid leukemia.
Harousseau JL; Milpied N; Briere J; Desablens B; Le Prise PY; Ifrah N; Gandhour C; Casassus P
Haematol Blood Transfus; 1990; 33():299-303. PubMed ID: 2323633
[No Abstract] [Full Text] [Related]
6. Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA Group.
Zittoun R; Mandelli F; Willemze R; de Witte T; Tura S; Ferrini PR; Stryckmans P; Gattringer C; Petti MC; Solbu G
Leukemia; 1992; 6 Suppl 2():114-5. PubMed ID: 1578909
[No Abstract] [Full Text] [Related]
7. Cure of acute myelocytic leukemia in adults: a reality.
Geller RB; Saral R; Karp JE; Santos GW; Burke PJ
Leukemia; 1990 May; 4(5):313-5. PubMed ID: 2201825
[TBL] [Abstract][Full Text] [Related]
8. The use of bone marrow cells grown in long-term culture for autologous bone marrow transplantation in acute myeloid leukaemia: an update.
Chang J; Morgenstern GR; Coutinho LH; Scarffe JH; Carr T; Deakin DP; Testa NG; Dexter TM
Bone Marrow Transplant; 1989 Jan; 4(1):5-9. PubMed ID: 2647188
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic BMT for AML in Zagreb.
Labar B; Bogdanić V; Nemet D; Mrsić M; Pavletić Z; Zupancić S; Radman I; Aurer I
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():86-7. PubMed ID: 2697413
[No Abstract] [Full Text] [Related]
10. Treatment of adults with acute myelogenous leukemia: prospective evaluation of high-dose cytarabine in consolidation chemotherapy and with bone marrow transplantation.
Champlin R; Ho W; Winston D; Decker R; Greenberg P; Burnison M; Holly FE; Gale RP
Semin Oncol; 1987 Jun; 14(2 Suppl 1):1-6. PubMed ID: 2438775
[No Abstract] [Full Text] [Related]
11. Malignant fibrous histiocytoma of bone.
Boland PJ; Huvos AG
Clin Orthop Relat Res; 1986 Mar; (204):130-4. PubMed ID: 3006959
[TBL] [Abstract][Full Text] [Related]
12. A randomized comparison of post-consolidation therapy in acute non-lymphoid leukaemia: a study of the Italian cooperative group GIMEMA.
Petti MC; Mandelli F; Vegna ML; Broccia G; Carotenuto M; De Rosa F; Di Marco P; Di Raimondo F; Fioritoni G; Leone G
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():119-20. PubMed ID: 2653486
[No Abstract] [Full Text] [Related]
13. Acute myelogenous leukemia associated with Ollier disease.
White MS; Martin PL; McLean TW
Pediatr Blood Cancer; 2008 Mar; 50(3):645-6. PubMed ID: 16991136
[TBL] [Abstract][Full Text] [Related]
14. Long term results in acute non-lymphocytic leukaemia.
Saikia TK; Rajni A; Gopal R; Nair CN; Nadkarni KS; Kurkure PA; Pai VR; Pai SK; Advani SH
J Assoc Physicians India; 1988 Aug; 36(8):505-7. PubMed ID: 3073153
[No Abstract] [Full Text] [Related]
15. The combined use of cytosine arabinoside, cyclophosphamide, and total body irradiation as preparative regimen for bone marrow transplantation in patients with AML and CML.
Messner HA; Curtis JE; Minden MM
Semin Oncol; 1985 Jun; 12(2 Suppl 3):187-9. PubMed ID: 3892701
[No Abstract] [Full Text] [Related]
16. [Comparison between intensive consolidation by bone marrow autograft or by chemotherapy of acute myeloblastic leukemias in 1st complete remission: AML8A protocol of the Leukemia Cooperative Group of the European Organization for Research and Treatment of Cancer (EORTC)].
Zittoun R; Rio B; Delmer A; Vekhof A; Mandelli F; Willemze R; de Witte T; Tura S; Ferrini PR; Stryckmans P
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):15-6. PubMed ID: 8511034
[No Abstract] [Full Text] [Related]
17. [Gastroenterologic findings in graft versus host disease after allogenic bone marrow transplantation].
Kreisel W; Fauser AA; Dölken G; Herbst EW
Z Gastroenterol; 1991 Jun; 29(6):289-93. PubMed ID: 1926962
[TBL] [Abstract][Full Text] [Related]
18. Remission of Crohn's disease following allogeneic bone marrow transplant for acute leukaemia.
Talbot DC; Montes A; Teh WL; Nandi A; Powles RL
Hosp Med; 1998 Jul; 59(7):580-1. PubMed ID: 9798551
[No Abstract] [Full Text] [Related]
19. [Neoadjuvant chemotherapy in malignant fibrous histiocytoma of the extremities. Preliminary results in 10 cases treated preoperatively with methotrexate and cisplatin].
Bettelli G; Avella M; Capanna R; Dallari D; Picci P; Campanacci M; Bacci G
Chir Organi Mov; 1987; 72(2):111-7. PubMed ID: 2824137
[No Abstract] [Full Text] [Related]
20. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
